节点文献

胰腺癌耐药性机制的研究现状

Research status on the mechanism of drug resistance in pancreatic cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈莞沁关秋彤黄晓娴魏敏杰李振华

【Author】 CHEN Wan-qin;GUAN Qiu-tong;HUANG Xiao-xian;WEI Min-jie;LI Zhen-hua;Department of Pharmacology,School of Pharmacy,China Medical University;

【通讯作者】 李振华;

【机构】 中国医科大学药学院药理教研室

【摘要】 胰腺癌(PC)属于消化道恶性肿瘤,早期难诊断,易转移和复发,对常规的放化疗有耐药性,是非常难治疗的疾病。PC耐药性的关键调节因子如上皮间-充质转换表型细胞、肿瘤干细胞、miRNA对耐药性机制产生的作用以及相关治疗策略早已在前些年有过相关综述,现如今新的一些调节因子已被发现,作为补充。本文侧重综述了PC化疗耐药性的关键调节因子(包括长非编码核糖核酸、核转录因子κB以及外泌体)的特征和性质、耐药性机制以及相关治疗策略,并对未来的治疗方向进行了预测和展望。

【Abstract】 Objective Pancreatic cancer(PC) is a malignant tumor of the digestive tract that is difficult to diagnose early, easily metastasizes and relapses, and resistant to conventional chemotherapy. PC is a very difficult disease to treat. The key regulatory factors of PC resistance, such as epithelial-mesenchymal transition phenotypic cells, tumor stem cells, and miRNAs, have been reviewed in the past few years, and some new regulatory factors have been discovered as supplements. This review mainly focuses on the characteristics and properties of the key regulatory factors of PC chemotherapy resistance including long noncoding RNAs, nuclear factor κB and exosomes, drug resistance mechanisms, and treatment related strategies, and future treatment directions were predicted.

【关键词】 胰腺癌耐药性化疗机制调节因子
【Key words】 pancreatic cancerdrug resistancechemotherapymechanismmodulator
【基金】 中国医科大学引进人才启动基金资助项目(1210619010);中国医科大学“双一流”建设专项基金资助项目(3110210603)
  • 【文献出处】 中国临床药理学杂志 ,The Chinese Journal of Clinical Pharmacology , 编辑部邮箱 ,2024年03期
  • 【分类号】R735.9
  • 【下载频次】213
节点文献中: 

本文链接的文献网络图示:

本文的引文网络